Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination. | Br J Dermatol;188(2): 163-165, 2023 02 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination.

Puig, Lluís.

Puig L; Department of Dermatology, IIB SANT PAU, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Br J Dermatol ; 188(2): 163-165, 2023 02 10.

Article in English | MEDLINE | ID: covidwho-2244386

Subject(s)

COVID-19; Psoriasis; Humans; COVID-19 Vaccines; Prospective Studies; COVID-19/prevention & control; Vaccination; Psoriasis/drug therapy

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Br J Dermatol Year: 2023 Document Type: Article Affiliation country: Bjd

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Br J Dermatol Year: 2023 Document Type: Article Affiliation country: Bjd